Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
In the DarTG toxin-antitoxin system, the DarT toxin ADP-ribosylates single-stranded DNA (ssDNA), which stalls DNA replication and plays a crucial role in controlling bacterial growth and bacteriophage infection. This toxic activity is reversed by the N-terminal macrodomain of the cognate antitoxin DarG. DarG also binds DarT, but the role of these interactions in DarT neutralization is unknown. Here, we report that the C-terminal domain of DarG (DarG toxin-binding domain [DarG]) interacts with DarT to form a 1:1 stoichiometric heterodimeric complex. We determined the 2.2 Å resolution crystal structure of the Mycobacterium tuberculosis DarT-DarG complex. The comparative structural analysis reveals that DarG interacts with DarT at the DarT/ssDNA interaction interface, thus sterically occluding substrate ssDNA binding and consequently inactivating toxin by direct protein-protein interactions. Our data support a unique two-layered DarT toxin neutralization mechanism of DarG, which is important in keeping the toxin molecules in check under normal growth conditions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.str.2023.04.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
"I Think I Could Have Used It Better": Experiences of Youth with High HbA1c Commencing Advanced Hybrid Closed-Loop Therapy in a Clinical Trial Setting-A Qualitative Research.
Pediatr Diabetes
April 2025
Children's Diabetes Centre Telethon Kids Institute The University of Western Australia, Perth, Australia.
Background: Advanced hybrid closed-loop (AHCL) therapy improves glycemia. However, it is not known if there is an improvement in overall outcomes with AHCL for youth with type 1 diabetes (T1D) at high risk of diabetes-related complications. The study aimed to capture the experiences of youth with suboptimal glycemic control when commencing AHCL therapy in a clinical trial setting.
View Article and Find Full Text PDFPhages carry orphan antitoxin-like enzymes to neutralize the DarTG1 toxin-antitoxin defense system.
Nat Commun
February 2025
Department of Molecular Microbiology, Washington University in Saint Louis School of Medicine, Saint Louis, MO, USA.
The astounding number of anti-phage defenses encoded by bacteria is countered by an elaborate set of phage counter-defenses, though their evolutionary origins are often unknown. Here, we report the discovery of an orphan antitoxin counter-defense element in T4-like phages that can overcome the bacterial toxin-antitoxin phage defense system, DarTG1. The DarT1 toxin, an ADP-ribosyltransferase, modifies phage DNA to prevent replication while its cognate antitoxin, DarG1, is a NADAR superfamily ADP-ribosylglycohydrolase that reverses these modifications in uninfected bacteria.
View Article and Find Full Text PDFRapid high-throughput screening of multiple typical mycotoxins in cereals.
Food Chem
February 2025
Suzhou Municipal Center for Disease Prevention and Control, Suzhou 215004, China. Electronic address:
The co-contamination of multiple mycotoxins in cereals brings serious food safety hazards. This work proposes a magnetic solid-phase extraction method based on polydopamine coated magnetic particles (FeO@PDA), coupled with direct analysis in real time mass spectrometry (DART-MS), for high-throughput screening of 17 mycotoxins in six categories in rice, corn and wheat. The results suggest that FeO@PDA is capable of co-extraction of all the mycotoxins within 3 min (adsorption rate above 87.
View Article and Find Full Text PDFSporadic phage defense in epidemic mediated by the toxin-antitoxin system DarTG is countered by a phage-encoded antitoxin mimic.
mBio
October 2024
Department of Plant and Microbial Biology, University of California, Berkeley, California, USA.
Bacteria and their viral predators (phages) are constantly evolving to subvert one another. Many bacterial immune systems that inhibit phages are encoded on mobile genetic elements that can be horizontally transmitted to diverse bacteria. Despite the pervasive appearance of immune systems in bacteria, it is not often known if these immune systems function against phages that the host encounters in nature.
View Article and Find Full Text PDFGlycemic and Psychosocial Outcomes of Advanced Hybrid Closed-Loop Therapy in Youth With High HbA1c: A Randomized Clinical Trial.
Diabetes Care
January 2025
Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Australia.
Objective: To determine the efficacy of advanced hybrid closed-loop (AHCL) therapy in a high-risk cohort of youth on continuous subcutaneous insulin infusion (CSII) with or without continuous glucose monitoring (CGM) with suboptimal glycemia.
Research Design And Methods: In a 6-month multicenter clinical trial, youth with type 1 diabetes with mean and most recent HbA1c >8.5% (65 mmol/mol) were randomly assigned 1:1 to AHCL or treatment as usual (CSII ± CGM).